Breaking News Instant updates and real-time market news.

TWX

Time Warner

$92.05

0.16 (0.17%)

, CMCSA

Comcast

$42.44

-0.16 (-0.38%)

18:52
01/15/18
01/15
18:52
01/15/18
18:52

Box Office Battle: 'Jumanji' wins weekend again

Sony's (SNE) "Jumanji: Welcome to the Jungle" maintained the top spot at the domestic box office for the second consecutive weekend, earning $28.1M from 3,849 theaters. The Dwayne Johnson and Kevin Hart-led remake has received an A- CinemaScore and got a 77% from Rotten Tomatoes. BOX OFFICE RUNNERS-UP: 21st Century Fox (FOXA) "The Post" came in second, posting solid numbers as it expanded nationwide into 2,819 theaters. Steven Spielberg's movie earned $19.3M for the four-day holiday weekend. Behind it was Lionsgate's (LGF.A) newcomer "The Commuter," with $13.7M from almost 2,900 theaters. 21st Century Fox's "The Greatest Showman" placed number four, earning $12.5M and closing in on the $100M mark. Rounding out the top five, Comcast's (CMCSA; CMCSK) "Insidious: The Last Key" ended the holiday weekend with $12.45M from 3,150 theaters. Other publicly traded companies in filmmaking include Viacom (VIAB), Walt Disney (DIS) and Warner Bros. (TWX).

TWX

Time Warner

$92.05

0.16 (0.17%)

CMCSA

Comcast

$42.44

-0.16 (-0.38%)

CMCSK

Comcast

$58.00

(0.00%)

SNE

Sony

$50.03

-0.25 (-0.50%)

FOX

21st Century Fox

$36.37

0.57 (1.59%)

FOXA

21st Century Fox

$36.73

0.53 (1.46%)

LGF.A

Lionsgate

$33.71

0.43 (1.29%)

DIS

Disney

$112.47

1.48 (1.33%)

VIAB

Viacom

$33.76

2.95 (9.57%)

VIA

Viacom

$39.10

3.45 (9.68%)

  • 18

    Jan

  • 24

    Jan

  • 24

    Jan

  • 06

    Feb

  • 07

    Feb

  • 07

    Feb

  • 08

    Feb

  • 08

    Feb

  • 08

    Feb

TWX Time Warner
$92.05

0.16 (0.17%)

01/04/18
WELS
01/04/18
NO CHANGE
Target $98
WELS
Market Perform
Time Warner price target raised to $98 from $84 at Wells Fargo
Wells Fargo analyst Marci Ryvicker raised her price target for Time Warner to $98 from $84 to incorporate tax reform. The analyst reiterates a Market Perform rating on the shares.
11/21/17
NOMU
11/21/17
NO CHANGE
Target $42
NOMU
Buy
AT&T price target lowered to $42 from $45 at Nomura Instinet
Nomura Instinet analyst Jeffrey Kvaal lowered his price for AT&T (T) shares target to $42 after the Justice Department filed a lawsuit to block the company's acquisition of Time Warner (TWX). The analyst notes he didn't lowered his target post the Q3 video miss given the pending deal. He believes the shares have "room to run" with or without Time Warner and keeps a Buy rating on AT&T.
12/04/17
JEFF
12/04/17
NO CHANGE
Target $194
JEFF
Hold
Jefferies sees Aetna trading at 10% discount to deal price
Jefferies analyst David Windley sees Aetna (AET) trading at a 10% spread to the $207 per share price paid by CVS Health (CVS) given the deal's "regulatory hurdles." The analyst sees Aetna trading today to $186 per share. Aetna in premarket trading is up 3%, or $5.99, to $187.30. Windley raised his price target for the stock to $194 from $185 and keeps a Hold rating on the name. The Department of Justice's stance on another major vertical integration, AT&T's (T) acquisition of Time Warner (TWX), suggests the CVS, Aetna transaction could face "significant scrutiny," Windley tells investors in a research note. He believes the regulatory cycle will likely take 9-12 months and may require some Part D divestitures.
11/29/17
KEYB
11/29/17
NO CHANGE
KEYB
Q3 results, analysis of Q4 viewership trends show some bright spots, says KeyBanc
KeyBanc analyst Andy Hargreaves notes that the Department of Justice's decision to sue to block AT&T (T)/Time Warner (TWX) seems likely to halt additional M&A until a resolution is reached. Additionally, the analyst points out that Q4 viewership trends appear most positive for Discovery (DISCA), Viacom (VIAB) so far, and 21st Century Fox (FOXA) remains his favorite long among TV network stocks.
CMCSA Comcast
$42.44

-0.16 (-0.38%)

01/12/18
01/12/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Facebook (FB) downgraded to Hold from Buy at Stifel with analyst Scott Devitt arguing there is currently "too much uncertainty" relating to the economic impact of the company's pending News Feed changes communicated in a post last night by CEO Mark Zuckerberg. 2. Snap (SNAP) downgraded to Underperform from Market Perform at Raymond James with analyst Aaron Kessler saying Snap is largely a Chat/Message app and not a camera company as it refers to itself. 3. Etsy (ETSY) downgraded to Underweight from Equal Weight at Morgan Stanley with analyst Brian Nowak citing valuation as being too expensive compared to its peers and the stock's historical average. 4. Comcast (CMCSA) downgraded to Buy from Action List Buy at TD Securities with analyst Vince Valentin citing recent shares strength and to make room of new Action List addition Shaw Communications (SJR), where he now sees better upside potential. 5. Electronic Arts (EA) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Brian Nowak citing disappointing "Star Wars: Battlefront 2" third party data. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/11/18
JPMS
01/11/18
NO CHANGE
Target $34
JPMS
Overweight
TiVo undervalued even without Comcast, says JPMorgan
JPMorgan analyst Sterling Auty still expects TiVo (TIVO) to ultimately resolve the situation with Comcast (CMCSA) in a "positive form that is value creating for shareholders." To better understand the impact, however, the analyst removed Comcast from his TiVo estimates. This resulted in his 2018 earnings per share estimate dropping to $1.75 from $1.85. TiVo stock appears undervalued even without Comcast, Auty tells investors in a research note. He keeps an Overweight rating on the shares with a $34 price target. The analyst notes that his price target assumes a positive resolution with Comcast.
01/11/18
PIPR
01/11/18
NO CHANGE
Target $25
PIPR
Overweight
Piper confident TiVo can renew with Comcast as legal fight continues
After TiVo (TIVO) reported that it has filed new lawsuits against Comcast (CMCSA) and said it plans to further a prior ITC court win, Piper Jaffray analyst Michael Olson said he believes these additional suits are intended to show that TiVo is not backing down in its legal battle. The analyst, who said he has a high degree of confidence in the company successfully renewing with Comcast, keeps his Overweight rating and $25 price target on TiVo shares.
01/12/18
TDSI
01/12/18
DOWNGRADE
Target $51
TDSI
Buy
Comcast downgraded to Buy from Action List Buy at TD Securities
TD Securities analyst Vince Valentin downgraded Comcast (CMCSA) to Buy given recent shares strength and to make room of new Action List addition Shaw Communications (SJR), where he now sees better upside potential.
CMCSK Comcast
$58.00

(0.00%)

12/11/17
BTIG
12/11/17
NO CHANGE
BTIG
BTIG says Comcast could pay 'significantly' more for Fox assets than Disney
BTIG analyst Richard Greenfield said earlier in a note to investors that he believes Comcast (CMCSA) could pay "significantly more" for the assets that Fox (FOXA) is reportedly looking to sell than could Disney (DIS). He also believes Comcast could have a better chance of securing regulatory approval for a deal if they are willing to spin off all of the regional sports networks that a combined entity would own.
11/22/17
PIPR
11/22/17
NO CHANGE
Target $25
PIPR
Overweight
TiVo ITC win raises odds of Comcast renewal, says Piper Jaffray
Piper Jaffray analyst Michael Olson said the International Trade Commission ruling in favor of TiVo (TIVO) increases the likelihood that a renewal deal with Comcast (CMCSA) will be reached, but he does not have it built into his estimates until early 2018. He maintains an Overweight rating and $25 price target on TiVo shares, which are up nearly 13% to $19.90 in pre-market trading.
01/09/18
MSCO
01/09/18
NO CHANGE
Target $50
MSCO
Overweight
Comcast price target raised to $50 on tax reform benefits at Morgan Stanley
Morgan Stanley analyst Benjamin Swinburne raised his FY18 and FY19 EPS estimates for Comcast, each by 20%, calling it the "big tax winner" as he views the company specifically, and cable in general, as among the largest tax reform beneficiaries in the market. The analyst, who also cites expectations for strong organic growth in its Cable segment and the benefits of this being both an Olympics and Super Bowl year at NBC in supporting his view that Comcast can outperform in 2018, raised his price target on the stock to $50 from $44 and keeps an Overweight rating on the name.
SNE Sony
$50.03

-0.25 (-0.50%)

12/07/17
BARD
12/07/17
NO CHANGE
BARD
Data so far suggesting healthy holiday game sales, says Baird
Baird analyst Colin Sebastian noted that French game maker Ubisoft (UBSFY) raised its revenue and margin guidance for the December quarter, which he views as a slight positive for video game industry sales momentum this holiday season. Data also point to solid sales for both Sony's (SNE) PS4 and Nintendo's (NTDOY) Switch, which are a driver of software as well as a key catalyst for Gamestop (GME), Sebastian added. Other publicly traded companies in the video game space include Activision Blizzard (ATVI), Electronic Arts (EA), Take-Two (TTWO) and Microsoft (MSFT).
11/17/17
RILY
11/17/17
NO CHANGE
Target $36
RILY
Neutral
21st Century Fox price target raised to $36 from $29 at B. Riley FBR
B. Riley FBR analyst Barton Crockett raised his price target for 21st Century Fox (FOXA) to $36 citing recent reports that Disney (DIS), Comcast (CMCSA), Verizon (VZ) or Sony (SNE) may make offers for the company. The "formerly unthinkable" prospect of Rupert Murdoch selling assets is likely to be factored into the equity price for some time, Crockett tells investors in a research. He keeps a Neutral rating on Fox given the stock's proximity to his new target.
10/11/17
10/11/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Schlumberger (SLB) downgraded to Market Perform from Outperform at BMO Capital with analyst Daniel Boyd saying he sees risk to 2018 estimates and limited room for multiple expansion. 2. Sony (SNE) downgraded to Equal Weight from Overweight at Morgan Stanley 3. Chico's (CHS) downgraded to Underperform from Neutral at BofA/Merrill with analyst Lorraine Hutchinson saying the premium multiple is unwarranted. 4. Robert Half (RHI) downgraded to Hold from Buy at SunTrust with analyst Tobey Sommer citing the recent underperformance relative to the U.S. staffing market and moderating growth of accounting jobs. 5. Coach (COH) downgraded to Neutral from Outperform at Consumer Edge. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/11/17
MSCO
10/11/17
DOWNGRADE
MSCO
Equal Weight
Sony downgraded to Equal Weight from Overweight at Morgan Stanley
FOX 21st Century Fox
$36.37

0.57 (1.59%)

12/13/17
FBNS
12/13/17
NO CHANGE
FBNS
FBN says Fox could be worth over $42 per share with Disney deal
With multiple media report indicating that Disney (DIS) is close to finalizing a deal to buy most of 21st Century Fox's (FOX) assets and operations, FBN Securities analyst Robert Routh is estimating that Fox shares could have a "real value" of $42.46 based on what has been reported on the likely deal. This estimate is before considering taxes and taking into account that Disney shares will likely rise after a deal is confirmed, said Routh, who does not officially cover either Disney or Fox.
12/13/17
BTIG
12/13/17
NO CHANGE
BTIG
Disney, Fox deal may be a near-term positive for Netflix, BTIG says
Commenting on Disney's (DIS) deal with Fox (FOX; FOXA) and its potential implications, BTIG's Richard Greenfield notes that the knee jerk reaction he hears across the investment world is the former is buying the later to build their "Netflix killer." Greenfield "strongly disagrees" with this viewpoint, saying that if Disney wanted to build a Netflix competitor it should be eliminating its stock buyback and aggressively investing in content that has no legacy media strings attached. Further, the Disney/Fox transaction is likely a near-to-intermediate term positive for Netflix, he argues, adding that both companies will be tied up in a 12 month or more regulatory review process with thousands of executives in limbo pending the closing of the transaction.
12/18/17
UBSW
12/18/17
NO CHANGE
Target $122
UBSW
Buy
Disney deal for Fox fits both strategically and financially, says UBS
UBS analyst John Hodulik said Disney's (DIS) deal for Fox (FOXA) strengthens its asset base amid the evolving media landscape and fits well both strategically and financially. He believes the deal enhances Disney's growth trajectory and will be accretive to 2020 free cash flow while helping it widen its appeal and target audience. Hodulik reiterated his Buy rating and $122 price target on Disney shares.
FOXA 21st Century Fox
$36.73

0.53 (1.46%)

01/10/18
BOFA
01/10/18
NO CHANGE
Target $144
BOFA
Buy
Disney price target raised to $144 from $130 at BofA/Merrill
BofA/Merrill analyst Jessica Reif Cohen raised her price target for Disney (DIS) to $144 from $130 as she believes it offers a "solid" catalyst pipeline for upside potential in 2018/2019, driven by a strong film release slate, a potential spring analyst event to discuss direct-to-consumer strategy, the opening of Toy Story Land, DTC/Hulu, and accelerating buybacks ahead of its pending 21st Century Fox (FOXA) acquisition. The analyst also projects Disney's Q1 will reflect healthy Studio and Theme Park trends, partially offset by unfavorable comps at Consumer Products and ratings headwinds/streaming investments Media Networks. Cohen reiterates a Buy rating on Disney's shares.
01/09/18
PIVT
01/09/18
DOWNGRADE
PIVT
Hold
21st Century Fox downgraded to Hold from Buy at Pivotal Research
01/04/18
WELS
01/04/18
NO CHANGE
WELS
Media sector upgraded to Over Weight from Market Weight at Wells Fargo
Wells Fargo analyst Marci Ryvicker upgraded the Media sector to Over Weight from Market Weight citing her positive views on shares of 21st Century Fox (FOXA), Disney (DIS), CBS (CBS) and AMC Networks (AMCX). Fox is the analyst's top near-term pick in the space, with Disney "a close second."
01/03/18
RBCM
01/03/18
NO CHANGE
Target $43
RBCM
Outperform
21st Century Fox price target raised to $43 from $34 at RBC Capital
RBC Capital analyst Steven Cahall raised his price target on 21st Century Fox (FOXA) to $43 and kept his Outperform rating in the wake of the asset sale to Disney (DIS). Cahall says the valuation on the SpinCo implies a 20% free cash flow yield relative to 7% at its peer CBS (CBS), and expects this discount to be corrected with an upside in the stock once the deal is fully priced in. The analyst also sees the immediate outlook for the company's revenue growth as "solid".
LGF.A Lionsgate
$33.71

0.43 (1.29%)

12/06/17
ARGS
12/06/17
NO CHANGE
Target $38
ARGS
Buy
Lionsgate price target raised to $38 from $34 at Argus
Argus analyst Joseph Bonner raised his price target on Lionsgate to $38, saying that despite the decline in Q2 revenue from lower Motion Picture segment sales, profitability improved amid higher margins in the Starz buinsess. The analyst says the company is focused on less expensive and more narrowly targeted films and building out the acquired Starz segment. Bonner keeps his Buy rating, noting the management has successfully integrated past acquisitions and adding that the Starz deal should lead to "smoother, more predictable profits and greater distribution scale for the company's original film and television content".
12/04/17
MSCO
12/04/17
NO CHANGE
Target $35
MSCO
Overweight
Lionsgate well positioned in rapidly changing media world, says Morgan Stanley
Morgan Stanley analyst Benjamin Swinburne said he is more bullish on the value of Starz given its OTT momentum and he believes Lionsgate's assets are well positioned for growth in the rapidly changing world of video and media. The analyst, who also highlights the value of the company's strategic assets against the backdrop of consolidation in the industry, raised his price target on Lionsgate shares to $35 from $32 and keeps an Overweight rating on the name.
11/14/17
FBNS
11/14/17
NO CHANGE
FBNS
Lionsgate Q2 report better than expected, says FBN Securities
FBN Securities analyst Robert Routh maintained an Outperform rating and $37.71 price target, citing better than expected second quarter results on the top and bottom lines, strong subscriber growth during the quarter for Lionsgate's Starz division, and FY18 guidance the company should reach.
01/03/18
RBCM
01/03/18
NO CHANGE
Target $40
RBCM
Outperform
Lionsgate price target raised to $40 from $36 at RBC Capital
RBC Capital analyst Steven Cahall raised his price target on Lions Gate Entertainment (LGF.B) to $40, calling it his "Top smidcap" for 2018. Cahall says that the company is a "content pureplay", which makes it defensive to changes in the ecosystem, adding that it is also the "most likely acquisition target in the space." The analyst points to reduction in earnings volatility through Starz, which he believes has an upside to its current distribution of 25M subscriptions. While there have been a number of potential suitors that want to own content, Cahall believes CBS (CBS) is the most "logical" one.
DIS Disney
$112.47

1.48 (1.33%)

01/03/18
RSBL
01/03/18
UPGRADE
Target $130
RSBL
Buy
Disney upgraded to Buy from Neutral at Rosenblatt
Rosenblatt analyst Alan Gould upgraded Disney to Buy from Neutral and raised his price target on the shares to $130 from $115.
VIAB Viacom
$33.76

2.95 (9.57%)

01/02/18
MACQ
01/02/18
DOWNGRADE
MACQ
Underperform
Viacom downgraded to Underperform from Neutral at Macquarie
01/02/18
BRRR
01/02/18
DOWNGRADE
BRRR
Market Perform
Viacom downgraded to Market Perform from Outperform at Barrington
01/02/18
BRRR
01/02/18
DOWNGRADE
BRRR
Market Perform
Viacom downgraded to Market Perform after rally at Barrington
As previously reported, Barrington analyst James Goss downgraded Viacom to Market Perform from Outperform, noting that a recent rally in the stock has priced in some of the upside he expected from the company's turnaround efforts and that recovery, particularly at the Paramount, will remain "largely in the future."
01/04/18
WELS
01/04/18
NO CHANGE
Target $32
WELS
Market Perform
Viacom price target raised to $32 from $25 at Wells Fargo
Wells Fargo analyst Marci Ryvicker raised her price target for Viacom to $32 from $25 to incorporate tax reform. The analyst reiterates a Market Perform rating on the shares.
VIA Viacom
$39.10

3.45 (9.68%)

11/20/17
DBAB
11/20/17
UPGRADE
Target $25
DBAB
Hold
Viacom upgraded to Hold from Sell at Deutsche Bank
Deutsche Bank analyst Bryan Kraft upgraded Viacom to Hold saying he sees limited room for further multiple compression. The analyst believes reports of merger speculation in the media space should provide valuation support and he keeps a $25 price target for Viacom shares.
11/20/17
11/20/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Verizon (VZ) upgraded to Outperform from Market Perform at Wells Fargo with analyst Jennifer Fritzsche saying after dropping 16% since mid-January, "much of the bad news is behind the stock" in terms of wireless service revenue declines. 2. 3D Systems (DDD) upgraded to Neutral from Underweight at Piper Jaffray with analyst Troy Jensen saying he sees limited downside from current share levels. 3. Viacom (VIAB, VIA) upgraded to Hold from Sell at Deutsche Bank with analyst Bryan Kraft saying he sees limited room for further multiple compression. 4. Maxwell (MXWL) upgraded to Buy from Neutral at Roth Capital with analyst Craig Irwin saying he sees consensus estimates as achievable for 2018, and merger synergies with NessCap should start making a more material contribution over the next few quarters. 5. National Beverage (FIZZ) upgraded to Positive from Neutral at Susquehanna with analyst Pablo Zuanic citing his increased conviction on the sales and bottom-line upside of the company. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
12/27/17
LOOP
12/27/17
NO CHANGE
Target $27
LOOP
Hold
Loop trims Viacom price target to $27 on 'Downsizing' disappointment
Loop Capital analyst David Miller lowered his Q1 estimates for Viacom after "Downsizing" came in a far third at the domestic box office in its holiday weekend opening against "Last Jedi" and "Jumanji," noting this is "the latest in a long line of Studio misfires this year." He trimmed his price target on Viacom shares to $27 from $28 and maintains a Hold rating on the stock.

TODAY'S FREE FLY STORIES

HIBB

Hibbett Sports

$21.70

-0.1 (-0.46%)

08:04
06/19/18
06/19
08:04
06/19/18
08:04
Recommendations
Hibbett Sports analyst commentary  »

Hibbett Sports weakness a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FBNK

First Connecticut

$26.05

0.15 (0.58%)

08:03
06/19/18
06/19
08:03
06/19/18
08:03
Hot Stocks
Breaking Hot Stocks news story on First Connecticut »

First Connecticut trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PTC

PTC

$97.80

2.93 (3.09%)

, ANSS

Ansys

$177.91

0.17 (0.10%)

08:03
06/19/18
06/19
08:03
06/19/18
08:03
Recommendations
PTC, Ansys, Rockwell Automation analyst commentary  »

PTC price target raised…

PTC

PTC

$97.80

2.93 (3.09%)

ANSS

Ansys

$177.91

0.17 (0.10%)

ROK

Rockwell Automation

$175.40

-2.19 (-1.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

NCR

NCR Corp.

$32.23

0.06 (0.19%)

08:03
06/19/18
06/19
08:03
06/19/18
08:03
Hot Stocks
NCR Corp. announces strategic alliance with TCS »

NCR Corp. announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DEA

Easterly Government Properties

$20.17

0.14 (0.70%)

08:03
06/19/18
06/19
08:03
06/19/18
08:03
Syndicate
Easterly Government Properties 18M share Spot Secondary priced at $19.25 »

The company increased the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

CLBS

Caladrius

$4.05

-0.015 (-0.37%)

08:02
06/19/18
06/19
08:02
06/19/18
08:02
Hot Stocks
Caladrius receives FDA RMAT designation for CD34+ cell therapy »

Caladrius Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBPO

China Biologic

$99.29

17.39 (21.23%)

08:02
06/19/18
06/19
08:02
06/19/18
08:02
Hot Stocks
China Biologic receives acquisition proposal from CCRE for $110 cash per share »

China Biologic announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XPO

XPO Logistics

$114.10

0.215 (0.19%)

08:02
06/19/18
06/19
08:02
06/19/18
08:02
Initiation
XPO Logistics initiated  »

XPO Logistics resumed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TREX

Trex Company

$64.61

1.675 (2.66%)

08:02
06/19/18
06/19
08:02
06/19/18
08:02
Hot Stocks
Trex Company announces effectiveness of 2-for-1 stock split »

Trex Company announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

G

Genpact

$30.84

-0.095 (-0.31%)

08:01
06/19/18
06/19
08:01
06/19/18
08:01
Hot Stocks
Genpact awarded patent for natural language understanding by USPTO »

Genpact announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ULH

Universal Logistics

$26.50

0.15 (0.57%)

08:01
06/19/18
06/19
08:01
06/19/18
08:01
Initiation
Universal Logistics initiated  »

Universal Logistics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 20

    Jun

LSTR

Landstar System

$115.30

0.25 (0.22%)

08:00
06/19/18
06/19
08:00
06/19/18
08:00
Initiation
Landstar System initiated  »

Landstar System resumed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRTX

Mirati Therapeutics

$49.15

0.3 (0.61%)

08:00
06/19/18
06/19
08:00
06/19/18
08:00
Recommendations
Mirati Therapeutics analyst commentary  »

Mirati Therapeutics price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 28

    Jun

ECHO

Echo Global

$30.40

-0.15 (-0.49%)

08:00
06/19/18
06/19
08:00
06/19/18
08:00
Initiation
Echo Global initiated  »

Echo Global resumed with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 20

    Jun

CHRW

C.H. Robinson

$90.67

0.57 (0.63%)

07:59
06/19/18
06/19
07:59
06/19/18
07:59
Initiation
C.H. Robinson initiated  »

C.H. Robinson resumed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Aug

TTPH

Tetraphase

$4.20

-0.05 (-1.18%)

07:59
06/19/18
06/19
07:59
06/19/18
07:59
Conference/Events
Tetraphase has a conference call hosted by SunTrust »

SunTrust will host a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 25

    Jun

  • 28

    Aug

BTE

Baytex Energy

$3.40

-0.47 (-12.16%)

07:56
06/19/18
06/19
07:56
06/19/18
07:56
Upgrade
Baytex Energy rating change  »

Baytex Energy upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNAP

Snap

$14.05

(0.00%)

07:56
06/19/18
06/19
07:56
06/19/18
07:56
Recommendations
Snap analyst commentary  »

Snap survey shows usage…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:55
06/19/18
06/19
07:55
06/19/18
07:55
General news
U.S. chain store sales rose 1.4% in the week ended June 16 »

U.S. chain store sales…

HSGX

Histogenics

$2.87

-0.1 (-3.37%)

07:55
06/19/18
06/19
07:55
06/19/18
07:55
Conference/Events
Histogenics to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

TDG

TransDigm

$340.12

0.06 (0.02%)

07:54
06/19/18
06/19
07:54
06/19/18
07:54
Recommendations
TransDigm analyst commentary  »

TransDigm poised to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

MDGL

Madrigal Pharmaceuticals

$306.24

6.23 (2.08%)

, BMY

Bristol-Myers

$53.65

-1.155 (-2.11%)

07:54
06/19/18
06/19
07:54
06/19/18
07:54
Downgrade
Madrigal Pharmaceuticals, Bristol-Myers, Nektar rating change  »

Madrigal cut to In Line…

MDGL

Madrigal Pharmaceuticals

$306.24

6.23 (2.08%)

BMY

Bristol-Myers

$53.65

-1.155 (-2.11%)

NKTR

Nektar

$58.40

0.545 (0.94%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 10

    Jul

RHT

Red Hat

$176.26

1.27 (0.73%)

07:53
06/19/18
06/19
07:53
06/19/18
07:53
Downgrade
Red Hat rating change  »

Red Hat downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jun

GLT

Glatfelter

$18.95

0.1 (0.53%)

07:49
06/19/18
06/19
07:49
06/19/18
07:49
Hot Stocks
Glatfelter to acquire Georgia-Pacific's European nonwovens business for $185M »

Glatfelter announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BLUE

Bluebird Bio

$176.50

-6.25 (-3.42%)

, CELG

Celgene

$77.71

-0.38 (-0.49%)

07:48
06/19/18
06/19
07:48
06/19/18
07:48
Upgrade
Bluebird Bio, Celgene rating change  »

Bluebird Bio upgraded to…

BLUE

Bluebird Bio

$176.50

-6.25 (-3.42%)

CELG

Celgene

$77.71

-0.38 (-0.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.